We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Carbylan BioSurgery Announces Positive Clinical Trial Results for Hydros-TA in Patients With Pain From Knee Osteoarthritis
Carbylan BioSurgery Announces Positive Clinical Trial Results for Hydros-TA in Patients With Pain From Knee Osteoarthritis
July 28, 2011
Carbylan BioSurgery announced positive results in its double-blinded, multi-center COR1.0 clinical trial which evaluated the safety and effectiveness of Hydros-TA Joint Therapy (Hydros-TA) and Hydros as compared to Synvisc-One in patients with osteoarthritis of the knee. Pipeline Review
